HIV and Coronary Heart Disease Time for a Better Understanding

被引:211
作者
Boccara, Franck [1 ,2 ]
Lang, Sylvie [1 ]
Meuleman, Catherine [1 ]
Ederhy, Stephane [1 ]
Mary-Krause, Murielle [3 ,4 ]
Costagliola, Dominique [3 ,4 ]
Capeau, Jacqueline [2 ]
Cohen, Ariel [1 ]
机构
[1] Univ Paris, St Antoine Hosp, Dept Cardiol, F-75252 Paris, France
[2] Univ Paris, Coll Med, INSERM, F-75252 Paris, France
[3] INSERM, Paris, France
[4] Univ Paris, Coll Med, F-75252 Paris, France
关键词
atherosclerosis; chronic inflammation; coronar heart disease; human immunodeficiency virus; immune activation; HUMAN-IMMUNODEFICIENCY-VIRUS; ACUTE MYOCARDIAL-INFARCTION; ACTIVE ANTIRETROVIRAL THERAPY; INTIMA-MEDIA THICKNESS; CLINICAL-TRIALS GROUP; C-REACTIVE PROTEIN; INFECTED PATIENTS; ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION;
D O I
10.1016/j.jacc.2012.06.063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease, and particularly coronary heart disease, is an emerging area of concern in the HIV population. Since the advent of efficient antiretroviral therapies and the consequent longer patient life span, an increased risk for myocardial infarction has been observed in HIV-infected patients compared with the general population in Western countries. The pathophysiology of this accelerated atherosclerotic process is complex and multifactorial. Traditional cardiovascular risk factors-overrepresented in the HIV population-associated with uncontrolled viral replication and exposure to antiretroviral drugs (per se or through lipid and glucose disturbances) could promote acute ischemic events. Thus, despite successful antiviral therapy, numerous studies suggest a role of chronic inflammation, together with immune activation, that could lead to vascular dysfunction and atherothrombosis. It is time for physicians to prevent coronary heart disease in this high-risk population through the use of tools employed in the general population. Moreover, the lower median age at which acute coronary syndromes occur in HIV-infected patients should shift prevention to include patients <45 years of age. Available cardiovascular risk scores in the general population usually fail to screen young patients at risk for myocardial infarction. Moreover, the novel vascular risk factors identified in HIV-related atherosclerosis, such as chronic inflammation, immune activation, and some antiretroviral agents, are not taken into account in the available risk scores, leading to underestimation of cardiovascular risk in the HIV population. Cardiovascular prevention in HIV-infected patients is a challenge for both cardiologists and physicians involved in HIV care. We require new tools to assess this higher risk and studies to determine whether intensive primary prevention is warranted. (J Am Coll Cardiol 2013; 61: 511-23) (C) 2013 by the American College of Cardiology Foundation
引用
收藏
页码:511 / 523
页数:13
相关论文
共 110 条
[91]   HIV infection and high density lipoprotein metabolism [J].
Rose, Honor ;
Hoy, Jennifer ;
Woolley, Ian ;
Tchoua, Urbain ;
Bukrinsky, Michael ;
Dart, Anthony ;
Sviridov, Dmitri .
ATHEROSCLEROSIS, 2008, 199 (01) :79-86
[92]   Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children [J].
Ross, Allison C. ;
O'Riordan, Mary Ann ;
Storer, Norma ;
Dogra, Vikram ;
McComsey, Grace A. .
ATHEROSCLEROSIS, 2010, 211 (02) :492-498
[93]   Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy [J].
Ross, Allison C. ;
Rizk, Nesrine ;
O'Riordan, Mary Ann ;
Dogra, Vikram ;
El-Bejjani, Dalia ;
Storer, Norma ;
Harrill, Danielle ;
Tungsiripat, Marisa ;
Adell, Jerome ;
McComsey, Grace A. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (07) :1119-1127
[94]   Platelet function and HIV: a case-control study [J].
Satchell, Claudette S. ;
Cotter, Aoife G. ;
O'Connor, Eileen F. ;
Peace, Aaron J. ;
Tedesco, Anthony F. ;
Clare, Andrew ;
Lambert, John S. ;
Sheehan, Gerard J. ;
Kenny, Dermot ;
Mallon, Patrick W. G. .
AIDS, 2010, 24 (05) :649-657
[95]   Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population [J].
Savès, M ;
Chêne, G ;
Ducimetière, P ;
Leport, C ;
Le Moal, G ;
Amouyel, P ;
Arveiler, D ;
Ruidavets, JB ;
Reynes, J ;
Bingham, A ;
Raffi, F .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :292-298
[96]   HIV Protease Inhibitors Induced Prolongation of the QT Interval: Electrophysiology and Clinical Implications [J].
Singh, Mukesh ;
Arora, Rohit ;
Jawad, Evyan .
AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (06) :E193-E201
[97]  
The antiretroviral therapy cohort collaboration, 2010, CLIN INFECT DIS, V50, P1387
[98]   Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort [J].
Tien, Phyllis C. ;
Choi, Andy I. ;
Zolopa, Andrew R. ;
Benson, Constance ;
Tracy, Russell ;
Scherzer, Rebecca ;
Bacchetti, Peter ;
Shlipak, Michael ;
Grunfeld, Carl .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (03) :316-322
[99]   Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy -: The ACTG (AIDS Clinical Trials Group) study 5152s [J].
Torriani, Francesca J. ;
Komarow, Lauren ;
Parker, Robert A. ;
Cotter, Bruno R. ;
Currier, Judith S. ;
Dube, Michael P. ;
Fichtenbaum, Carl J. ;
Gerschenson, Mariana ;
Mitchell, Carol K. C. ;
Murphy, Robert L. ;
Squires, Kathleen ;
Stein, James H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (07) :569-576
[100]   Cardiac surgery in patients infected with the human immunodeficiency virus [J].
Trachiotis, GD ;
Alexander, EP ;
Benator, D ;
Gharagozloo, F .
ANNALS OF THORACIC SURGERY, 2003, 76 (04) :1114-1118